Physician profile
Tristan Dow
NPI 1063503597
$3,562.44
in general payments reported to CMS, 2019-2025
6 companies · $1,432 in 2025
The $1,432 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.08 · 2020: $21.89 · 2021: $121 · 2022: $77.68 · 2023: $1,301 · 2024: $523 · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,677 · Travel and Lodging: $1,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,676.81 |
| Travel and Lodging | $1,578.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,050.33 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Abbott Laboratories | $1,245.00 | 2019-2025 | Cardiomems |
| Edwards Lifesciences Corporation | $186.04 | 2020-2024 | Evoque |
| Atricure, INC. | $38.44 | 2021-2024 | |
| Akcea Therapeutics, INC. | $27.11 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $15.52 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tristan Dow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.